Trial intelligence / Profile preview

Iron loading and iron chelation during human endotoxemia

NL-OMON33343Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of iron sucrose, deferasirox and lipopolysaccharide endotoxin in sepsis (5 arms), sponsored by Radboud University Medical Center. Primary endpoint: Circulating cytokine concentrations after LPS administration. Started Nov 2009; status: active, not recruiting.

02

Drugs

iron sucrosedeferasiroxlipopolysaccharide endotoxin
03

Conditions

sepsis

Beyond the preview

Go deeper on NL-OMON33343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call